[Phrenic nerve conduction in amyotrophic lateral sclerosis patients].

Objective: To investigate the features and application of phrenic nerve conduction in amyotrophic lateral scle-rosis (ALS) patients.

Methods: The latency and amplitude of diaphragmatic compound muscle action potential (DCMAP) were recorded among 44 ALS patients and 31 control subjects with surface electrodes after the cervical part of phrenic nerve was stimulated with electricity. The percentage of forced vital capacity (%FVC) was examined in 28 ALS patients simultaneously.

TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator.

DR3 is a death domain-containing receptor that is upregulated during T cell activation and whose overexpression induces apoptosis and NF-kappaB activation in cell lines. Here we show that an endothelial cell-derived TNF-like factor, TL1A, is a ligand for DR3 and decoy receptor TR6/DcR3 and that its expression is inducible by TNF and IL-1alpha. TL1A induces NF-kappaB activation and apoptosis in DR3-expressing cell lines, while TR6-Fc protein antagonizes these signaling events.